India News | One-shot Sputnik Light Vaccine Shows 70 Pc Efficacy Against Coronavirus' Delta Variant: RDIF

New Delhi, Oct 13 (PTI) The Russian Direct Investment Fund (RDIF) and Gamaleya Center on Wednesday said one-shot Sputnik Light vaccine demonstrates 70 per cent efficacy against infection with the Delta variant of coronavirus during the first three months after vaccination.

Gamaleya Center has submitted an article analysing efficacy of Sputnik Light vaccine against the Delta variant to the medRxiv preprint server for health sciences, RDIF said in a statement.

Also Read | OnePlus 9RT 5G With Snapdragon 888 SoC & 4,500mAh Battery Launched.

The analysis was conducted based on data from 28,000 participants who had received a single dose of Sputnik Light, compared with a control group of 5.6 million individuals who were not vaccinated. The data used in the study was collected in July 2021 in Moscow, it added.

"The vaccine is more than 75 per cent effective among subjects under the age of 60. Sputnik Light also provides much higher efficacy against severe disease and hospitalisations," RDIF said in a statement.

Also Read | Amritsar Man Duped Of Rs 1.97 Lakh By Online Fraudster Posing As Bank Official; Case Registered.

The one-shot Sputnik Light vaccine is authorised in more than 15 countries, with ongoing registration processes in another 30 countries, it added.

"The Delta variant of coronavirus is one of the most common and dangerous strains. The data analysis presented in the article by the Gamaleya Center demonstrates that Sputnik Light remains highly effective months after vaccination," Gamaleya Center Deputy Director Denis Logunov said.

The vaccine's one-shot regimen makes it as a strong solution for countries with low vaccination rates. Sputnik Light can also be successfully used to maintain existing herd immunity as a booster shot, he added.

On the development, RDIF Chief Executive Officer Kirill Dmitriev said, "The efficacy results of the one-shot Sputnik Light vaccine against the Delta variant of coronavirus significantly outperform those of a number of two-shot vaccines."

Sputnik Light is safe and highly effective when used both on a standalone basis and when combined with other vaccines, he added.

"RDIF actively supports research into combinations of Sputnik Light with other vaccines and has also invited independent international researchers and scientific institutions to cooperate on real-world studies of safety and efficacy of coronavirus vaccines," Dmitriev said. HRS hrs

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)